Navigation Links
Phase 3 Topical Drug for Raynaud's Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
Date:12/13/2012

BOTHELL, Wash., Dec. 13, 2012 /PRNewswire-iReach/ -- MediQuest Therapeutics Inc., a specialty pharmaceutical company focused on inflammatory skin diseases and conditions, today announced that they will be conducting partnering/M&A meetings at the J.P. Morgan 31st Annual Healthcare Conference between January 7th and 10th in San Francisco, regarding its Phase 3 topical formulation, VASCANA, designed to treat Raynaud's Disease, an unmet medical need. MediQuest is also selling/licensing the remainder of its topical assets including a skin lightener, ready for commercialization.  Its topical/non-systemic Onychomycosis drug was out-licensed in August 2012.

(Photo: http://photos.prnewswire.com/prnh/20121213/CG29278)

MediQuest's VASCANA has a Special Protocol Assessment granted by the Federal Food & Drug Administration for a single Phase 3 study involving approximately 150 patients that suffer from moderate to severe symptoms of Raynaud's Syndrome.  VASCANA has a strong safety profile and an extensive intellectual property portfolio with issued patents that run to 2026.   The peak sales in the United States is estimated at about $250 million, as well as similar markets in EU and Asia, with low cost of goods, supported by 2-years of stability data.

Any company interested in learning more about VASCANA can arrange to meet with MediQuest at the J.P. Morgan conference through the below contact information.  

About Raynaud's Disease
An estimated 9-11 million people in the United States suffer from Raynaud's Disease, 2.1 million of which have been diagnosed and are seeking medical treatment. Raynaud's patients can experience severe pain associated with chronic vasospasm episodes in their hands, feet and other extremities.

About MediQuest Therapeutics, Inc.
MediQuest Therapeutics is a specialty pharmaceutical company using its proprie
'/>"/>

SOURCE MediQuest Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
2. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
3. Insero Health Completes Phase I Trial of Novel Therapy in Patients With Drug Resistant Epilepsy
4. Unigenes Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
5. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
6. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
7. uniQure Initiates Phase I in Acute Intermittent Porphyria
8. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
11. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (Nasdaq: LMNX ) today announced that it expects ... Monday, February 3, 2014. A press release announcing the results ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the fourth quarter and twelve months ended ...
(Date:1/14/2014)... Pa. , Jan. 14, 2014 Dynamic Healthcare Services, ... announced today that it acquired Progressive Home Medical Equipment, Inc. ... 7, 2014. The terms of the acquisition were not disclosed. ... equipment ("DME") company providing a wide range of sleep, mobility, ...
(Date:1/14/2014)... NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service the ... NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, options ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... A recent article in Arizona ,s Gilbert Examiner ... the launch of " PPA 2.0 ," the organization,s online expansion of the program. ... PPA has helped more than 6.5 ... provide free or nearly free medications. "This achievement in Arizona is especially ...
... Working with an internal whistleblower, Attorney Warner Mendenhall , the ... Alex Rokakis and Michelle Heyer have worked for four years ... , , , ... investigation, St. Jude has agreed to return $3,898,300 to the federal ...
Cached Medicine Technology:Arizona Residents Get Help With Medicines Through PPA 2.0 2Arizona Residents Get Help With Medicines Through PPA 2.0 3St. Jude Medical and Hospitals in Ohio and Kentucky to Pay Almost $4 Million to Federal Government to Resolve Fraud Allegations 2
(Date:4/22/2014)... may throw tantrums like toddlers, but their total ... say, a gerbil or fox squirrel, according to ... and birds ranging from orangutans to zebra finches. ... Yale and more than two-dozen other research institutions ... evolution of self-control, defined in the study as ...
(Date:4/22/2014)... LOS ANGELES (April 22, 2014) Cedars-Sinai stroke intervention ... Neurological Disorders and Stroke, part of the National Institutes ... fund a multicenter Phase II clinical trial of an ... will be used in combination with recombinant tissue plasminogen ... to treat ischemic strokes shortly after onset. In laboratory ...
(Date:4/22/2014)... We,ve all waited in line and most of us ... we would like. , For Will Mather, assistant ... of Science,s Integrated Science Curriculum, studying lines, or queues, ... deal with bottlenecks that limit the recycling of proteins. ... an assistant professor, has received attention from the National ...
(Date:4/22/2014)... A new prediction tool can help doctors better identify ... after surgery and therefore prevent the often deadly condition, ... the May issue of Anesthesiology . , Affecting ... (ARDS) is a sudden failure of the lungs caused ... to pneumonia or blood infection. High-risk patients can develop ...
(Date:4/21/2014)... OAK BROOK, Ill. Imaging of the coronary arteries ... of arterial plaque and could have a dramatic impact ... high risk of heart attacks and other cardiovascular events, ... the journal Radiology . , Plaque that forms ... in some cases, rupture, leading to potentially fatal heart ...
Breaking Medicine News(10 mins):Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:Queuing theory helps physicist understand protein recycling 2Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 3
... could boost sensitivity, amount of information offered by the ... could some day be injected into the body to ... amount of information provided by the images, according to ... act as "smart tags" that identify specific cells, tissues, ...
... of Survivor Cafe Continues Longstanding ... Community Support By Binson,s, DETROIT, June 18 The fight ... Komen Detroit Race for,the Cure(R) with the participation of 344 participants from ... the Komen Race for the Cure Series has been a celebration,of life, ...
... research awards to states in 2007 created more than ... from those new jobs, and,spurred more than $50 billion ... for NIH Threatens New Health Research, U.S.,Medical Leadership, and ... Institutes,of Health has a legacy of great medical accomplishments, ...
... VW Bus For Fundraising Contest, HERNDON, Va., June ... their hands on legendary rock band The Who,s Magic,Bus ... 1965, signed by Roger,Daltrey and Pete Townshend and specially ... target logo. The competition, in aid of Daltrey,s,charity Teenage ...
... June 21, 2008, New Alternatives,for Children (NAC), a New ... disabilities and/or chronic illnesses, will,hold its 3rd Annual NAC ... 12:00 noon to 3:30 pm rain or shine., ... family members,are expected to participate in the 2008 NAC ...
... June 18 After 25 years, 26 chapters,and more ... the brink of a new era. And, beginning in ... alike can read the latest news,and cutting-edge technologies with ... available, in its entirety, online, offering readers,more opportunities to ...
Cached Medicine News:Health News:'Micromagnets' May One Day Enhance MRI Technology 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 3Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 4Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 2Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 3Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 2Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 3Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 3Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 2Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 3
... The Foundation® PS knee offers a femoral option ... cam action that engages at 60 degrees of ... motion and allow for 130 degrees of flexion. ... design with prominent lateral flare. The constrained tibial ...
... System is designed to provide the surgeon ... clinical indications. Based on the clinically successful ... P.F.C. SIGMA continues a history of innovation ... to address implant longevity by maximizing femoro-tibial ...
... Knee System's curved-on-curved articulation maintains full inter-changeability. ... for better patient fit. The Maxim ... knee's proven concepts with expanded options to ... Maxim is indicated for use in total ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
Medicine Products: